Citations

Citations to this article as recorded by  

• Molecular and cellular mechanisms involved in tissue-specific metabolic modulation by SARS-CoV-2
  Alef Aragão Carneiro dos Santos, Luiz Eduardo Rodrigues, Amanda Lins Alecrim-Zeza, Liliane de Araújo Ferreira, Caio dos Santos Trettel, Gabriela Mandú Gimenes, Adelson Fernandes da Silva, Celso Pereira Batista Sousa-Filho, Tamires Duarte Afonso Serdan, Ad
  Frontiers in Microbiology.2022;[Epub]     CrossRef
• Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review
  Amany Magdy Beshbishy, Victor B. Oti, Diaa E. Hussein, Ibrahim F. Rehan, Oluyomi S. Adeyemi, Nallely Rivero-Perez, Adrian Zaragoza-Bastida, Muhammad Ajmal Shah, Khaled Abouelezz, Helal F. Hetta, Natália Cruz-Martins, Gaber El-Saber Batiha
  Frontiers in Public Health.2021;[Epub]     CrossRef
• Digital health services among patients with diabetes during the COVID-19 pandemic: A scoping review
  NiK D. Purnamayanti, AnggiL Wicaksana
  Indian Journal of Endocrinology and Metabolism.2021; 25(2): 86.     CrossRef

Since the first case was contracted by coronavirus disease-19 (COVID-19) in Daegu, Korea in February 2020, about 6,800 cases and 130 deaths have been reported on April 9, 2020. Recent studies have reported that patients with diabetes showed higher mortality and they had a worse prognosis than the group without diabetes. In poorly controlled patients with diabetes, acute hyperglycemic crises such as diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS) also might be precipitated by COVID-19. Thus, intensive monitoring and aggressive supportive care should be needed to inadequately controlled patients with diabetes and COVID-19 infection. Here, we report two cases of severe COVID-19 patients with acute hyperglycemic crises in Korea.

Citations

Citations to this article as recorded by  

• Clinical Characteristics and Predictors of Mortality in Obese African-Americans with COVID-19: a Single-Center Retrospective Study
  Pavani Reddy Garlapati, Suneet Kumar, Meet Patel, Bidyut Sarker, Benjamin Tiongson, Sreedhar Adapa, Sohail Abdul Salim, Mark K. Adler, Vijay Reddy Gayam
  Journal of Racial and Ethnic Health Disparities.2023; 10(1): 160.     CrossRef
• Diabetes and the COVID-19 pandemic
  Kamlesh Khunti, Jonathan Valabhji, Shivani Misra
  Diabetologia.2023; 66(2): 255.     CrossRef
• Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination
  Hyeyeon Moon, Sunghwan Suh, Mi Kyoung Park
  Journal of Korean Medical Science.2023;[Epub]     CrossRef
• COVID‐19 associated ketosis and diabetic ketoacidosis: A rapid review
  Tharun T. Alamuri, Sandhya Mahesh, Kevin Dell'Aquila, Taylor Jan Leong, Rebecca Jennings, Tim Q. Duong
  Diabetes, Obesity and Metabolism.2023; 25(7): 1785.     CrossRef
• Risks associated with acute pancreatitis (AP) with diabetic ketoacidosis (DKA) in COVID-19 patients: a literature review
  Sundru Manjulata Devi, Annapurna Pamreddy, Venkata Ramana Narendra
  Journal of Diabetes & Metabolic Disorders.2023; 22(1): 135.     CrossRef
• A Review of Hyperglycemia in COVID-19
  Maryam Zahedi, Saba Kordrostami, Mohammadreza Kalantarhormozi, Marziyeh Bagheri
  Cureus.2023;[Epub]     CrossRef
• A UK nationwide study of adults admitted to hospital with diabetic ketoacidosis or hyperosmolar hyperglycaemic state and COVID‐19
  Benjamin C. T. Field, Yue Ruan, Kinga A. Várnai, Jim Davies, Robert E. J. Ryder, Rajiv Gandhi, Sophie Harris, Dinesh Nagi, Dipesh Patel, Punith Kempegowda, Sarah H. Wild, Emma G. Wilmot, Kamlesh Khunti, Rustam Rea, Parth Narendran
  Diabetes, Obesity and Metabolism.2023; 25(7): 2012.     CrossRef
• Diabetic Ketoacidosis in COVID-19 Patients: Clinical Characteristics and Outcomes – A Retrospective Study in a Single Tertiary Care Hospital, Dubai, United Arab Emirates
  Hana AL Sughaiyer, Abeer AL Haj, Samia Murad Ibrahim Abdulrahman
  Dubai Diabetes and Endocrinology Journal.2023; 29(2): 107.     CrossRef
• COVID-19 and diabetes
  Artur Furga
  Probacja.2023; 3: 235.     CrossRef
• COVID-19 SALGININDA DİYABET YÖNETİMİ VE HEMŞİRENİN ROLÜ
  Dilek BÜYÜKKAYA BESEN, Merve DERVİŞOĞLU
  Gazi Sağlık Bilimleri Dergisi.2022; 7(2): 78.     CrossRef
• Diabetic ketoacidosis and COVID-19: what have we learned so far?
  Caio Oliveira de Sá-Ferreira, Camila Helena Macedo da Costa, João Campos Wiltgen Guimarães, Nathasha Souza Sampaio, Leticia de Moraes Lopes Silva, Larissa Paula de Mascarenhas, Nicollas Garcia Rodrigues, Talita Labonia dos Santos, Solange Campos, Esther C
  American Journal of Physiology-Endocrinology and Metabolism.2022; 322(1): E44.     CrossRef
• COVID-19 and hyperglycaemic emergencies: perspectives from a developing country
  Raisa Bhikoo, Marli Conradie-Smit, Gerhard Van Wyk, Sa’ad Lahri, Elizabeth Du Plessis, Jaco Cilliers, Susan Hugo, Ankia Coetzee
  Journal of Endocrinology, Metabolism and Diabetes of South Africa.2022; 27(1): 42.     CrossRef
• Potential impact of combined influenza and pneumococcal vaccines on the severity of respiratory illness in COVID-19 infection among type 2 diabetic patients
  Amr Shaaban Hanafy, Waseem M. Seleem, Hany A. Elkattawy
  Clinical and Experimental Medicine.2022;[Epub]     CrossRef
• The COVID-19-diabetes mellitus molecular tetrahedron
  Mehdi Mahmudpour, Katayoun Vahdat, Mohsen Keshavarz, Iraj Nabipour
  Molecular Biology Reports.2022; 49(5): 4013.     CrossRef
• Diabetes and COVID-19; A Bidirectional Interplay
  Paraskevi Kazakou, Vaia Lambadiari, Ignatios Ikonomidis, Aikaterini Kountouri, Georgios Panagopoulos, Stavros Athanasopoulos, Eleni Korompoki, Ioannis Kalomenidis, Meletios A. Dimopoulos, Asimina Mitrakou
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
  Qin Ning, Di Wu, Xiaojing Wang, Dong Xi, Tao Chen, Guang Chen, Hongwu Wang, Huiling Lu, Ming Wang, Lin Zhu, Junjian Hu, Tingting Liu, Ke Ma, Meifang Han, Xiaoping Luo
  Signal Transduction and Targeted Therapy.2022;[Epub]     CrossRef
• Challenges in hyperglycemia management in critically ill patients with COVID-19
  Rajesh Kethireddy, Darshan Gandhi, Asim Kichloo, Love Patel
  World Journal of Critical Care Medicine.2022; 11(4): 219.     CrossRef
• New-Onset and Persistent Insulin-Dependent Diabetes in Patients With COVID-19: A Peruvian Experience
  Anthony Ramos-Yataco, Emanuel A Salcedo Davila, Kelly Meza, Inga Harbuz-Miller
  Cureus.2022;[Epub]     CrossRef
• Type 2 Diabetes Mellitus and COVID-19: A Narrative Review
  Cristina Rey-Reñones, Sara Martinez-Torres, Francisco M. Martín-Luján, Carles Pericas, Ana Redondo, Carles Vilaplana-Carnerero, Angela Dominguez, María Grau
  Biomedicines.2022; 10(9): 2089.     CrossRef
• SARS-CoV-2 Infections, Impaired Tissue, and Metabolic Health: Pathophysiology and Potential Therapeutics
  Shailendra Pratap Singh, Aayushi Bhatnagar, Sujeet Kumar Singh, Sanjib K. Patra, Navjot Kanwar, Abhinav Kanwal, Salomon Amar, Ranata Manna
  Mini-Reviews in Medicinal Chemistry.2022; 22(16): 2102.     CrossRef
• Collateral damage due to COVID-19
  Farhan Fazal, Nitin Gupta, Wasim Khot, Yogiraj Ray
  Tropical Doctor.2021; 51(1): 126.     CrossRef
• Diabetic emergencies during the COVID‐19 pandemic: A case–control study
  M. S. B. Huda, S. Shaho, B. Trivedi, G. Fraterrigo, L. Chandrarajan, P. Zolfaghari, T. M. Dovey, C. G. Garrett, T. A Chowdhury
  Diabetic Medicine.2021;[Epub]     CrossRef
• Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors
  Rebecca J. Vitale, Yannis K. Valtis, Marie E. McDonnell, Nadine E. Palermo, Naomi D.L. Fisher
  AACE Clinical Case Reports.2021; 7(1): 10.     CrossRef
• Outcomes and Healthcare Provider Perceptions of Real-Time Continuous Glucose Monitoring (rtCGM) in Patients With Diabetes and COVID-19 Admitted to the ICU
  Kenneth W. Chow, Danielle J. Kelly, Mary C. Rieff, Patricia A. Skala, Igor Kravets, Marina M. Charitou, Eric J. Morley, Rajarsi Gupta, Joshua D. Miller
  Journal of Diabetes Science and Technology.2021; 15(3): 607.     CrossRef
• Diabetic ketoacidosis presented with COVID-19 infection: A rare case report
  Deniz Çekiç, Selçuk Yaylacı, Sümeyye Çekiç, Kubilay İşsever, Hamad Dheir, Havva Kocayiğit, Mehmet Halil Öztürk, Oğuz Karabay
  Journal of Clinical Medicine of Kazakhstan.2021; 18(1): 79.     CrossRef
• Renin-angiotensin system modulators and other risk factors in COVID-19 patients with hypertension: a Korean perspective
  Hee-Sung Kim, Minseok Kang, Gilwon Kang
  BMC Infectious Diseases.2021;[Epub]     CrossRef
• Increased Incidence of Pediatric Diabetic Ketoacidosis After COVID-19: A Two-Center Retrospective Study in Korea
  Min Jeong Han, Jun Ho Heo
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 783.     CrossRef
• Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications
  Andrey Santos, Daniéla Oliveira Magro, Rosana Evangelista-Poderoso, Mario José Abdalla Saad
  Diabetology & Metabolic Syndrome.2021;[Epub]     CrossRef
• Neuropsychiatric Symptoms of COVID-19 Explained by SARS-CoV-2 Proteins’ Mimicry of Human Protein Interactions
  Hale Yapici-Eser, Yunus Emre Koroglu, Ozgur Oztop-Cakmak, Ozlem Keskin, Attila Gursoy, Yasemin Gursoy-Ozdemir
  Frontiers in Human Neuroscience.2021;[Epub]     CrossRef
• COVID-19 and Diabetic Ketoacidosis: Report of Eight Cases
  Balraj Singh, Prem Patel , Parminder Kaur , Nicole Majachani, Michael Maroules
  Cureus.2021;[Epub]     CrossRef
• Machine Learning Applied to Clinical Laboratory Data in Spain for COVID-19 Outcome Prediction: Model Development and Validation
  Juan L Domínguez-Olmedo, Álvaro Gragera-Martínez, Jacinto Mata, Victoria Pachón Álvarez
  Journal of Medical Internet Research.2021; 23(4): e26211.     CrossRef
• Effect of COVID-19 on management of type 1 diabetes: Pushing the boundaries of telemedical healthcare
  Ines Bilic Curcic, Maja Cigrovski Berkovic, Tomislav Kizivat, Silvija Canecki Varzic, Robert Smolic, Martina Smolic
  World Journal of Diabetes.2021; 12(6): 780.     CrossRef
• COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course
  Cyril P. Landstra, Eelco J. P. de Koning
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Real-World Studies Support Use of Continuous Glucose Monitoring in Type 1 and Type 2 Diabetes Independently of Treatment Regimen
  James R. Gavin, Clifford J. Bailey
  Diabetes Technology & Therapeutics.2021; 23(S3): S-19.     CrossRef
• Evaluation of Characteristics and Outcomes for Patients with Diabetic Ketoacidosis (DKA) With and Without COVID-19 in Elmhurst Queens During Similar Three-Month Periods in 2019 and 2020
  Urja Patel, Linda Deluxe, Carlos Salama, Aaron Ross Jimenez, Adrian Whiting, Cedrick Lubin, Nancy Tarlin
  Cureus.2021;[Epub]     CrossRef
• Temporal trends in emergency admissions for diabetic ketoacidosis in people with diabetes in England before and during the COVID-19 pandemic: a population-based study
  Shivani Misra, Emma Barron, Eszter Vamos, Stephen Thomas, Ketan Dhatariya, Partha Kar, Bob Young, Kamlesh Khunti, Jonathan Valabhji
  The Lancet Diabetes & Endocrinology.2021; 9(10): 671.     CrossRef
• Diabetes mellitus and COVID-19: Understanding the association in light of current evidence
  Saikat Sen, Raja Chakraborty, Pratap Kalita, Manash Pratim Pathak
  World Journal of Clinical Cases.2021; 9(28): 8327.     CrossRef
• Follow-Up Study of the Cardiopulmonary and Psychological Outcomes of COVID-19 Survivors Six Months After Discharge in Sichuan, China
  Shuiping Dai, Bennan Zhao, Dafeng Liu, Yongzhao Zhou, Yaling Liu, Lijuan Lan, Yalun Li, Wenxin Luo, Yilan Zeng, Weimin Li
  International Journal of General Medicine.2021; Volume 14: 7207.     CrossRef
• Diabetic ketoacidosis in patients with SARS-CoV-2: a systematic review and meta-analysis
  Saad Alhumaid, Abbas Al Mutair, Zainab Al Alawi, Ali A. Rabaan, Mohammed A. Alomari, Sadiq A. Al Salman, Ahmed S. Al-Alawi, Mohammed H. Al Hassan, Hesham Alhamad, Mustafa A. Al-kamees, Fawzi M. Almousa, Hani N. Mufti, Ali M. Alwesabai, Kuldeep Dhama, Jaff
  Diabetology & Metabolic Syndrome.2021;[Epub]     CrossRef
• In-hospital clinical complications of COVID-19: a brief overview
  Kevin John John, Jemimah Nayar, Ajay Kumar Mishra, Vijairam Selvaraj, Mohammad Saud Khan, Amos Lal
  Future Virology.2021; 16(11): 717.     CrossRef
• Combined Hyperglycemic Hyperosmolar Syndrome and Diabetic Ketoacidosis Associated with COVID-19 in a Pediatric Patient
  Yu Shan Tseng, Bradley Tilford, Usha Sethuraman, Katherine Cashen, Mehmet Doganay
  Case Reports in Critical Care.2021; 2021: 1.     CrossRef
• Toddler With New Onset Diabetes and Atypical Hemolytic-Uremic Syndrome in the Setting of COVID-19
  Faraz Alizadeh, Amanda O’Halloran, Areej Alghamdi, Charlotte Chen, Maria Trissal, Avram Traum, Danielle DeCourcey
  Pediatrics.2021;[Epub]     CrossRef
• A Complicated Case of COVID-19 and Hyperglycemic Hyperosmolar Syndrome in an Adolescent Male
  Anisha Gohil, Stefan Malin, Kamal Abulebda, Tamara S. Hannon
  Hormone Research in Paediatrics.2021; 94(1-2): 71.     CrossRef
• COVID-19 in People with Diabetes: Perspectives from Saudi Arabia
  Asirvatham Alwin Robert, Mohamed Abdulaziz Al Dawish
  Current Diabetes Reviews.2021;[Epub]     CrossRef
• A Case of COVID-19 with Acute Myocardial Infarction and Cardiogenic Shock
  Hong Nyun Kim, Jang Hoon Lee, Hun Sik Park, Dong Heon Yang, Se Yong Jang, Myung Hwan Bae, Yongkeun Cho, Shung Chull Chae, Yong-Hoon Lee
  Journal of Korean Medical Science.2020;[Epub]     CrossRef
• Clinical profile and outcomes in COVID-19 patients with diabetic ketoacidosis: A systematic review of literature
  Rimesh Pal, Mainak Banerjee, Urmila Yadav, Sukrita Bhattacharjee
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2020; 14(6): 1563.     CrossRef
• Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations
  Nadine E Palermo, Archana R Sadhu, Marie E McDonnell
  The Journal of Clinical Endocrinology & Metabolism.2020; 105(8): 2819.     CrossRef
• A Case of Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State in a Patient With COVID-19
  Shemitha Rafique, Fahad W Ahmed
  Cureus.2020;[Epub]     CrossRef

• COVID’s Razor: RAS Imbalance, the Common Denominator Across Disparate, Unexpected Aspects of COVID-19

  
  Maureen Czick, Christine Shapter, Robert Shapter
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 3169.     CrossRef
• Letter: Acute Hyperglycemic Crises with Coronavirus Disease-19: Case Reports (Diabetes Metab J 2020;44:349–53)
  Ja Young Jeon
  Diabetes & Metabolism Journal.2020; 44(3): 480.     CrossRef
• COVID-19 in people with diabetes: understanding the reasons for worse outcomes
  Matteo Apicella, Maria Cristina Campopiano, Michele Mantuano, Laura Mazoni, Alberto Coppelli, Stefano Del Prato
  The Lancet Diabetes & Endocrinology.2020; 8(9): 782.     CrossRef
• Diabetes and COVID-19: Global and regional perspectives
  In-Kyung Jeong, Kun Ho Yoon, Moon Kyu Lee
  Diabetes Research and Clinical Practice.2020; 166: 108303.     CrossRef
• Hyperglycemia, Hypertriglyceridemia, and Acute Pancreatitis in COVID-19 Infection
  Chiranjeevi Gadiparthi, Mehak Bassi, Balaji Yegneswaran, Sammy Ho, Capecomorin S. Pitchumoni
  Pancreas.2020; 49(7): e62.     CrossRef
• Response: Acute Hyperglycemic Crises with Coronavirus Disease-19: Case Reports (Diabetes Metab J 2020;44:349–53)
  Na-young Kim, Eunyeong Ha, Jun Sung Moon, Yong-Hoon Lee, Eun Young Choi
  Diabetes & Metabolism Journal.2020; 44(3): 484.     CrossRef
• Diabetic ketoacidosis precipitated by COVID-19: A report of two cases and review of literature
  Pavan Kumar Reddy, Mohammad Shafi Kuchay, Yatin Mehta, Sunil Kumar Mishra
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2020; 14(5): 1459.     CrossRef
• COVID-19 and diabetes: What have we learned so far?
  Nida Taher, Mohammed SB Huda, Tahseen A Chowdhury
  Clinical Medicine.2020; 20(4): e87.     CrossRef
• High dose ascorbic acid treatment in COVID-19 patients raised some problems in clinical chemistry testing
  Fatih Yesildal, Ferruh Kemal Isman
  Turkish Journal of Biochemistry.2020; 45(5): 491.     CrossRef
• Coronavirus Disease 2019 and Diabetes: The Epidemic and the Korean Diabetes Association Perspective
  Junghyun Noh, Hyun-Ha Chang, In-Kyung Jeong, Kun Ho Yoon
  Diabetes & Metabolism Journal.2020; 44(3): 372.     CrossRef
• Practical considerations for pregnant women with diabetes and severe acute respiratory syndrome coronavirus 2 infection
  Glenn P. Boyles, Stephen Thung, Steven G. Gabbe, Mark B. Landon, Maged M. Costantine
  American Journal of Obstetrics & Gynecology MFM.2020; 2(4): 100210.     CrossRef
• Protracted ketonaemia in hyperglycaemic emergencies in COVID-19: a retrospective case series
  Eleni Armeni, Umaira Aziz, Sulmaaz Qamar, Sadia Nasir, Chidambaram Nethaji, Rupert Negus, Nicholas Murch, Huw Clarke Beynon, Pierre Bouloux, Miranda Rosenthal, Sidrah Khan, Ahmed Yousseif, Ravi Menon, Efthimia Karra
  The Lancet Diabetes & Endocrinology.2020; 8(8): 660.     CrossRef
• Development of a tablet PC-based portable device for colorimetric determination of assays including COVID-19 and other pathogenic microorganisms
  Woo Sik Yoo, Hyung Soo Han, Jung Gon Kim, Kitaek Kang, Hyo-Sung Jeon, Jin-Young Moon, Hyeonmi Park
  RSC Advances.2020; 10(54): 32946.     CrossRef
• Machine Learning to Predict Mortality and Critical Events in a Cohort of Patients With COVID-19 in New York City: Model Development and Validation
  Akhil Vaid, Sulaiman Somani, Adam J Russak, Jessica K De Freitas, Fayzan F Chaudhry, Ishan Paranjpe, Kipp W Johnson, Samuel J Lee, Riccardo Miotto, Felix Richter, Shan Zhao, Noam D Beckmann, Nidhi Naik, Arash Kia, Prem Timsina, Anuradha Lala, Manish Paran
  Journal of Medical Internet Research.2020; 22(11): e24018.     CrossRef
• COVID-19: the endocrine opportunity in a pandemic
  Subhankar Chatterjee, Ritwik Ghosh, Payel Biswas, Souvik Dubey, Rishi T. Guria, Chandra B. Sharma, Sanjay Kalra
  Minerva Endocrinologica.2020;[Epub]     CrossRef
• Management of Diabetes in Coronavirus Disease 2019: Prognosis and Practical Issues
  Hye Soon Kim
  The Journal of Korean Diabetes.2020; 21(3): 120.     CrossRef
• Short term follow-up of patients presenting with acute onset diabetes and diabetic ketoacidosis during an episode of COVID-19
  Mohammad Shafi Kuchay, Pavan Kumar Reddy, Sakshi Gagneja, Anu Mathew, Sunil Kumar Mishra
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2020; 14(6): 2039.     CrossRef
• Diabetic ketoacidosis precipitated by Coronavirus disease 2019 infection: Case series
  Ibrahim Alsadhan, Shahad Alruwashid, Maram Alhamad, Sarah Alajmi, Sara Alshehri, Eman Alfadhli, Aishah Ekhzaimy
  Current Therapeutic Research.2020; 93: 100609.     CrossRef
• Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients
  F.-J. Prado-Galbarro, C. Sanchez-Piedra, A.E. Gamiño-Arroyo, C. Cruz-Cruz
  Public Health.2020; 189: 66.     CrossRef
• SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in β Cells
  Katie C. Coate, Jeeyeon Cha, Shristi Shrestha, Wenliang Wang, Luciana Mateus Gonçalves, Joana Almaça, Meghan E. Kapp, Maria Fasolino, Ashleigh Morgan, Chunhua Dai, Diane C. Saunders, Rita Bottino, Radhika Aramandla, Regina Jenkins, Roland Stein, Klaus H.
  Cell Metabolism.2020; 32(6): 1028.     CrossRef
• Caring for Hospitalized Patients with Diabetes Mellitus, Hyperglycemia, and COVID-19: Bridging the Remaining Knowledge Gaps
  Amisha Wallia, Grace Prince, Emilie Touma, Malek El Muayed, Jane Jeffrie Seley
  Current Diabetes Reports.2020;[Epub]     CrossRef
• Recovery From Acute Kidney Injury With Diabetic Ketoacidosis Following SARS-CoV-2 Infection: A Case Report and Literature Review
  Chang Xu, Umer Zia
  Cureus.2020;[Epub]     CrossRef
• The Outbreak of COVID-19 and Diabetes in Korea: “We Will Find a Way as We Have Always Done”
  Kyu Chang Won, Kun Ho Yoon
  Diabetes & Metabolism Journal.2020; 44(2): 211.     CrossRef